Mitochondrial quality surveillance as a therapeutic target in myocardial infarction
- PMID: 33270362
- DOI: 10.1111/apha.13590
Mitochondrial quality surveillance as a therapeutic target in myocardial infarction
Abstract
Myocardial infarction (MI) is a leading cause of morbidity and mortality worldwide. As mitochondrial dysfunction critically contributes to the pathogenesis of MI, intensive research is focused on the development of therapeutic strategies targeting mitochondrial homeostasis. Mitochondria possess a quality control system which maintains and restores their structure and function by regulating mitochondrial fission, fusion, biogenesis, degradation and death. In response to slight damage such as transient hypoxia or mild oxidative stress, mitochondrial metabolism shifts from oxidative phosphorylation to glycolysis, in order to reduce oxygen consumption and maintain ATP output. Mitochondrial dynamics are also activated to modify mitochondrial shape and structure, in order to meet cardiomyocyte energy requirements through augmenting or reducing mitochondrial mass. When damaged mitochondria cannot be repaired, poorly structured mitochondria will be degraded through mitophagy, a process which is often accompanied by mitochondrial biogenesis. Once the insult is severe enough to induce lethal damage in the mitochondria and the cell, mitochondrial death pathway activation is an inevitable consequence, and the cardiomyocyte apoptosis or necrosis program will be initiated to remove damaged cells. Mitochondrial quality surveillance is a hierarchical system preserving mitochondrial function and defending cardiomyocytes against stress. A failure of this system has been regarded as one of the potential pathologies underlying MI. In this review, we discuss the recent findings focusing on the role of mitochondrial quality surveillance in MI, and highlight the available therapeutic approaches targeting mitochondrial quality surveillance during MI.
Keywords: fission; fusion; mitochondria-dependent cell death; mitochondrial quality surveillance; mitophagy; myocardial infarction.
© 2020 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.
Similar articles
-
Role of mitochondrial quality surveillance in myocardial infarction: From bench to bedside.Ageing Res Rev. 2021 Mar;66:101250. doi: 10.1016/j.arr.2020.101250. Epub 2020 Dec 31. Ageing Res Rev. 2021. PMID: 33388396 Review.
-
Irisin activates Opa1-induced mitophagy to protect cardiomyocytes against apoptosis following myocardial infarction.Aging (Albany NY). 2020 Mar 10;12(5):4474-4488. doi: 10.18632/aging.102899. Epub 2020 Mar 10. Aging (Albany NY). 2020. PMID: 32155590 Free PMC article.
-
TBC1D15/RAB7-regulated mitochondria-lysosome interaction confers cardioprotection against acute myocardial infarction-induced cardiac injury.Theranostics. 2020 Sep 14;10(24):11244-11263. doi: 10.7150/thno.46883. eCollection 2020. Theranostics. 2020. PMID: 33042281 Free PMC article.
-
Mitochondrial disorder and treatment of ischemic cardiomyopathy: Potential and advantages of Chinese herbal medicine.Biomed Pharmacother. 2023 Mar;159:114171. doi: 10.1016/j.biopha.2022.114171. Epub 2023 Jan 13. Biomed Pharmacother. 2023. PMID: 36641924 Review.
-
BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivo.Cardiovasc Pathol. 2016 May-Jun;25(3):258-269. doi: 10.1016/j.carpath.2016.02.004. Epub 2016 Mar 4. Cardiovasc Pathol. 2016. PMID: 27039070 Free PMC article.
Cited by
-
The structure and function of FUN14 domain-containing protein 1 and its contribution to cardioprotection by mediating mitophagy.Front Pharmacol. 2024 May 17;15:1389953. doi: 10.3389/fphar.2024.1389953. eCollection 2024. Front Pharmacol. 2024. PMID: 38828457 Free PMC article. Review.
-
SIRT3 and RORα are two prospective targets against mitophagy during simulated ischemia/reperfusion injury in H9c2 cells.Heliyon. 2024 May 8;10(10):e30568. doi: 10.1016/j.heliyon.2024.e30568. eCollection 2024 May 30. Heliyon. 2024. PMID: 38784556 Free PMC article.
-
Cardioprotective effect of antioxidant combination therapy: A highlight on MitoQ plus alpha-lipoic acid beneficial impact on myocardial ischemia-reperfusion injury in aged rats.Heliyon. 2024 Mar 14;10(6):e28158. doi: 10.1016/j.heliyon.2024.e28158. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38524576 Free PMC article.
-
PKM2 interacts with and phosphorylates PHB2 to sustain mitochondrial quality control against septic cerebral-cardiac injury.Int J Med Sci. 2024 Jan 21;21(4):633-643. doi: 10.7150/ijms.92367. eCollection 2024. Int J Med Sci. 2024. PMID: 38464826 Free PMC article.
-
Dual-specificity phosphatase 1 interacts with prohibitin 2 to improve mitochondrial quality control against type-3 cardiorenal syndrome.Int J Med Sci. 2024 Jan 19;21(3):547-561. doi: 10.7150/ijms.90484. eCollection 2024. Int J Med Sci. 2024. PMID: 38322592 Free PMC article.
References
REFERENCES
-
- Kramer P, Bressan P. Our (mother's) mitochondria and our mind. Perspect Psychol Sci. 2018;13(1):88-100.
-
- Tews D, Pula T, Funcke JB, et al. Elevated UCP1 levels are sufficient to improve glucose uptake in human white adipocytes. Redox Biol. 2019;26:101286.
-
- de Dios C, Bartolessis I, Roca-Agujetas V, et al. Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress. Redox Biol. 2019;26:101283.
-
- Picard M, McEwen BS. Psychological stress and mitochondria: a conceptual framework. Psychosom Med. 2018;80(2):126-140.
-
- Annesley SJ, Fisher PR. Mitochondria in health and disease. Cells. 2019;8:7.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials